Eraxis, Ecalta (anidulafungin) is a small molecule pharmaceutical. Anidulafungin was first approved as Eraxis on 2006-02-17. It is used to treat abdominal abscess, candidemia, mycoses, and peritonitis in the USA. It has been approved in Europe to treat candidiasis. Eraxis's patent is valid until 2021-04-12 (FDA).
|Indication||abdominal abscess, candidemia, candidiasis, mycoses, peritonitis|
|Drug Class||Antifungal antibiotics (undefined group)|